CF
TNDM icon

Corebridge Financial’s Tandem Diabetes Care TNDM Stock Holding History

Corebridge Financial’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,290
Closed -$657K – 2551
2025
Q1 		$657K Sell
34,290
-672
-2% -$19.7K ﹤0.01% 1448
2024
Q4 		$1.26M Sell
34,962
-2,238
-6% -$75.7K 0.01% 1228
2024
Q3 		$1.58M Sell
37,200
-359
-1% -$15.2K 0.01% 1151
2024
Q2 		$1.51M Buy
+37,559
New +$1.57M 0.01% 1121

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Corebridge Financial's TNDM Position: Q2 2025 in Review

Corebridge Financial sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 34,290 shares — an estimated $657K sold.

Corebridge Financial first reported a position in TNDM in Q2 2024 and held it in 4 quarters. The position peaked at $1.58M in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Corebridge Financial reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 34,290 Tandem Diabetes Care shares in Q2 2025, an estimated $657K.
  • Corebridge Financial first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Tandem Diabetes Care position peaked at $1.58M in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.